These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Asthma--the changing face of drug therapy. Legg J; Warner J Indian J Pediatr; 2000 Feb; 67(2):147-53. PubMed ID: 10832243 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulation as asthma therapy: where do we stand? Barnes PJ Eur Respir J Suppl; 1996 Aug; 22():154s-159s. PubMed ID: 8871062 [TBL] [Abstract][Full Text] [Related]
5. New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma. Thomson NC Expert Opin Pharmacother; 2017 Feb; 18(3):283-293. PubMed ID: 28099820 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors of tryptase for the treatment of mast cell-mediated diseases. Rice KD; Tanaka RD; Katz BA; Numerof RP; Moore WR Curr Pharm Des; 1998 Oct; 4(5):381-96. PubMed ID: 10197050 [TBL] [Abstract][Full Text] [Related]
7. Mast cell tryptase beta as a target in allergic inflammation: an evolving story. Sommerhoff CP; Schaschke N Curr Pharm Des; 2007; 13(3):313-32. PubMed ID: 17313363 [TBL] [Abstract][Full Text] [Related]
8. Role of mast cells and basophils in asthma. Redington AE; Polosa R; Walls AF; Howarth PH; Holgate ST Chem Immunol; 1995; 62():22-59. PubMed ID: 7546283 [No Abstract] [Full Text] [Related]
9. New approaches to the treatment of childhood asthma. Rabinovitch N; Gelfand EW Curr Opin Pediatr; 1998 Jun; 10(3):243-9. PubMed ID: 9716884 [TBL] [Abstract][Full Text] [Related]
11. Regulation of leukotrienes in the management of asthma: biology and clinical therapy. Leff AR Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764 [TBL] [Abstract][Full Text] [Related]
12. New drugs for asthma. Barnes PJ Eur Respir J; 1992 Oct; 5(9):1126-36. PubMed ID: 1358672 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Bisgaard H Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935 [TBL] [Abstract][Full Text] [Related]
14. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. de Paulis A; Ciccarelli A; MarinĂ² I; de Crescenzo G; MarinĂ² D; Marone G Arthritis Rheum; 1997 Mar; 40(3):469-78. PubMed ID: 9082935 [TBL] [Abstract][Full Text] [Related]
15. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Bentley AM; Hamid Q; Robinson DS; Schotman E; Meng Q; Assoufi B; Kay AB; Durham SR Am J Respir Crit Care Med; 1996 Feb; 153(2):551-6. PubMed ID: 8564096 [TBL] [Abstract][Full Text] [Related]
18. New approaches to anti-inflammatory therapy for asthma. Wenzel SE Am J Med; 1998 Mar; 104(3):287-300. PubMed ID: 9552092 [TBL] [Abstract][Full Text] [Related]
19. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306 [TBL] [Abstract][Full Text] [Related]
20. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Rubin P; Cohn J; White MV; Igarashi Y; Kaliner MA; Drazen JM J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):1046-56. PubMed ID: 7798537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]